[News Brief] Japan Approves Clinigen’s Therapeutic Human Milk Fortifier for VLBW Infants
Japan’s Ministry of Health, Labour and Welfare has approved a human milk-based fortifier for very low birth weight (VLBW) infants,…
Japan’s Ministry of Health, Labour and Welfare has approved a human milk-based fortifier for very low birth weight (VLBW) infants,…
South Korean healthcare company Kwangdong Pharmaceutical has entered the Singapore market with its Vita500 range of vitamin products, marking an…
Meiji Seika Pharma Co., Ltd. plans to establish a local subsidiary in Singapore in spring 2026 to strengthen its commercial…
Sun Pharmaceutical Industries has received approval from the Drug Controller General of India (DCGI) to manufacture a generic version of…
Akeso’s bispecific antibody ivonescimab has been included in FirstWord Pharma’s “Spotlight On: The Drugs That Will Shape 2026” list of…
China’s authorities have approved Enhertu (trastuzumab deruxtecan) as the first HER2-directed antibody-drug conjugate for patients with HER2-positive metastatic gastric cancer.…
Daiichi Sankyo has announced a leadership transition at its Translational Research Centre Europe, with Veronika Müller succeeding Jürgen Müller. This…
Kowa Co., Ltd has announced the launch in Singapore of GLA-ALPHA® Combination Ophthalmic Solution, a new fixed-dose eye drop licensed…
The Asia Summit on Global Health (ASGH) 2026 will be held at the Hong Kong Convention and Exhibition Centre from…
A report from China’s State Council Information Office shows that Chinese-made medicines and medical devices are gaining a stronger foothold…